Increases in plasma 25(OH)D levels are related to improvements in body composition and blood pressure in middle-aged subjects after a weight loss intervention: Longitudinal study

Clinical Nutrition

Volumn 34, Issue 5, 2015, Pages 1010-1017

  Ibero Baraibar, Idoia ^a   Navas Carretero, Santiago ^a,b   Abete, Itziar ^c   Martinez, J A ^a,b   Zulet, M A ^a,b  

^a UNIVERSITY OF NAVARRA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

Author keywords

Adiposity; Blood pressure; Fat mass; Inflammation; Middle aged; Vitamin D

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; 25 HYDROXYVITAMIN D; C REACTIVE PROTEIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; CARBOHYDRATE DIET; FAT INTAKE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN INTAKE; VITAMIN D;

ADULT; ANTHROPOMETRY; ARTICLE; BODY COMPOSITION; BODY MASS; BONE MINERAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; FAT MASS; FEMALE; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; LONGITUDINAL STUDY; MALE; OBESITY; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; VITAMIN BLOOD LEVEL; WEIGHT REDUCTION; ADMINISTRATION AND DOSAGE; AGED; BLOOD; BLOOD PRESSURE; CALORIC INTAKE; CARBOHYDRATE DIET; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; FAT INTAKE; METABOLISM; MIDDLE AGED; PATIENT COMPLIANCE; PROTEIN INTAKE; STATISTICAL MODEL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOMARKERS; BLOOD PRESSURE; BODY COMPOSITION; BODY MASS INDEX; C-REACTIVE PROTEIN; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIETARY CARBOHYDRATES; DIETARY FATS; DIETARY PROTEINS; DOUBLE-BLIND METHOD; ENERGY INTAKE; FEMALE; HUMANS; INTERLEUKIN-6; LINEAR MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PATIENT COMPLIANCE; TUMOR NECROSIS FACTOR-ALPHA; VITAMIN D; WEIGHT LOSS;

EID: 84939203918     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2014.11.004     Document Type: Article

References (30)

1. Medanic D., Pucarin-Cvetkovic J. Obesity-a public health problem and challenge. Acta Med Croat 2012, 66(5):347-355.
2. Adamczak M., Wiecek A. The adipose tissue as an endocrine organ. Semin Nephrol 2013, 33(1):2-13.
3. Balistreri C.R., Caruso C., Candore G. The role of adipose tissue and adipokines in obesity-related inflammatory diseases. Mediat Inflamm 2010, 802078.
4. Hollis B.W. Assessment of vitamin D status and definition of a normal circulating range of 25-hydroxyvitamin D. Curr Opin Endocrinol Diabetes Obes 2008, 15(6):489-494.
5. Botella-Carretero J.I., Alvarez-Blasco F., Villafruela J.J., Balsa J.A., Vazquez C., Escobar-Morreale H.F. Vitamin D deficiency is associated with the metabolic syndrome in morbid obesity. Clin Nutr 2007, 26(5):573-580.
6. Maddock J., Berry D.J., Geoffroy M.C., Power C., Hypponen E. Vitamin D and common mental disorders in mid-life: cross-sectional and prospective findings. Clin Nutr 2013, 32(5):758-764.
7. Stocklin E., Eggersdorfer M., Vitamin D. An essential nutrient with versatile functions in nearly all organs. Int J Vitam Nutr Res 2013, 83(2):92-100.
8. Vimaleswaran K.S., Berry D.J., Lu C., Tikkanen E., Pilz S., Hiraki L.T., et al. Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med 2013, 10(2):e1001383.
9. Foss Y.J. Vitamin D deficiency is the cause of common obesity. Med Hypotheses 2009, 72(3):314-321.
10. Blum M., Dolnikowski G., Seyoum E., Harris S.S., Booth S.L., Peterson J., et al. Vitamin D(3) in fat tissue. Endocrine 2008, 33(1):90-94.
11. Gonzalez-Molero I., Rojo-Martinez G., Morcillo S., Gutierrez-Repiso C., Rubio-Martin E., Almaraz M.C., et al. Vitamin D and incidence of diabetes: a prospective cohort study. Clin Nutr 2012, 31(4):571-573.
12. Ortega R.M., Aparicio A., Rodriguez-Rodriguez E., Bermejo L.M., Perea J.M., Lopez-Sobaler A.M., et al. Preliminary data about the influence of vitamin D status on the loss of body fat in young overweight/obese women following two types of hypocaloric diet. Br J Nutr 2008, 100(2):269-272.
13. Perez-Lopez F.R., Chedraui P., Fernandez-Alonso A.M. Vitamin D and aging: beyond calcium and bone metabolism. Maturitas 2011, 69(1):27-36.
14. Chung J.Y., Kang H.T., Lee D.C., Lee H.R., Lee Y.J. Body composition and its association with cardiometabolic risk factors in the elderly: a focus on sarcopenic obesity. Arch Gerontol Geriatr 2013, 56(1):270-278.
15. Ibero-Baraibar I., Abete I., Navas-Carretero S., Massis-Zaid A., Martinez J.A., Zulet M.A. Oxidised LDL levels decreases after the consumption of ready-to-eat meals supplemented with cocoa extract within a hypocaloric diet. Nutr Metab Cardiovasc Dis 2014, 24(4):416-422.
16. The National Academy Press Food and nutrition board 1989, National Research Council: Recomended dietary Allowances, Washington, DC. 10th ed.
17. de la Iglesia R., Lopez-Legarrea P., Celada P., Sanchez-Muniz F.J., Martinez J.A., Zulet M.A. Beneficial effects of the RESMENA dietary pattern on oxidative stress in patients suffering from metabolic syndrome with hyperglycemia are associated to dietary TAC and fruit consumption. Int J Mol Sci 2013, 14(4):6903-6919.
18. Concato J., Shah N., Horwitz R.I. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000, 22, 342(25):1887-1892.
19. Tzotzas T., Papadopoulou F.G., Tziomalos K., Karras S., Gastaris K., Perros P., et al. Rising serum 25-hydroxy-vitamin D levels after weight loss in obese women correlate with improvement in insulin resistance. J Clin Endocrinol Metab 2010, 95(9):4251-4257.
20. Mason C., Xiao L., Imayama I., Duggan C.R., Bain C., Foster-Schubert K.E., et al. Effects of weight loss on serum vitamin D in postmenopausal women. Am J Clin Nutr 2011, 94(1):95-103.
21. Mason C., Xiao L., Imayama I., Duggan C., Wang C.Y., Korde L., et al. Vitamin D3 supplementation during weight loss: a double-blind randomized controlled trial. Am J Clin Nutr 2014, 99(5):1015-1025.
22. Piccolo B.D., Dolnikowski G., Seyoum E., Thomas A.P., Gertz E.R., Souza E.C., et al. Association between subcutaneous white adipose tissue and serum 25-hydroxyvitamin D in overweight and obese adults. Nutrients 2013, 5(9):3352-3366.
23. Bhandari S.K., Pashayan S., Liu I.L., Rasgon S.A., Kujubu D.A., Tom T.Y., et al. 25-hydroxyvitamin D levels and hypertension rates. J Clin Hypertens (Greenwich) 2011, 13(3):170-177.
24. Wang L., Ma J., Manson J.E., Buring J.E., Gaziano J.M., Sesso H.D. A prospective study of plasma vitamin D metabolites, vitamin D receptor gene polymorphisms, and risk of hypertension in men. Eur J Nutr 2013, 52(7):1771-1779.
25. Vimaleswaran K.S., Power C., Hypponen E. Interaction between vitamin D receptor gene polymorphisms and 25-hydroxyvitamin D concentrations on metabolic and cardiovascular disease outcomes. Diabetes Metab 2014, 10.1016/j.diabet.2014.01.003.
26. Li Y.C., Qiao G., Uskokovic M., Xiang W., Zheng W., Kong J., et al. a negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol 2004, 89-90(1-5):387-392.
27. Ding C., Gao D., Wilding J., Trayhurn P., Bing C. Vitamin D signalling in adipose tissue. Br J Nutr 2012, 108(11):1915-1923.
28. Ching S., Kashinkunti S., Niehaus M.D., Zinser G.M. Mammary adipocytes bioactivate 25-hydroxyvitamin D(3) and signal via vitamin D(3) receptor, modulating mammary epithelial cell growth. J Cell Biochem 2011, 112(11):3393-3405.
29. Kim M., Na W., Sohn C. Correlation between vitamin D and cardiovascular disease predictors in overweight and obese Koreans. J Clin Biochem Nutr 2013, 52(2):167-171.
30. Laird E., McNulty H., Ward M., Hoey L., McSorley E., Wallace J.M., et al. Vitamin d deficiency is associated with inflammation in older irish adults. J Clin Endocrinol Metab 2014, 99(5):1807-1815.